TransMedics Group, Inc.
TMDX
$121.31
-$7.66-5.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.78% | -8.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.78% | -8.61% | |||
| Cost of Revenue | 13.67% | -2.52% | |||
| Gross Profit | 10.45% | -12.44% | |||
| SG&A Expenses | 11.79% | 4.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.74% | -0.23% | |||
| Operating Income | -8.70% | -36.28% | |||
| Income Before Tax | -6.07% | -36.35% | |||
| Income Tax Expenses | -6,402.33% | -201.02% | |||
| Earnings from Continuing Operations | 333.34% | -30.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 333.34% | -30.33% | |||
| EBIT | -8.70% | -36.28% | |||
| EBITDA | -3.78% | -32.22% | |||
| EPS Basic | 331.97% | -30.74% | |||
| Normalized Basic EPS | -6.37% | -36.71% | |||
| EPS Diluted | 290.26% | -28.15% | |||
| Normalized Diluted EPS | -6.48% | -36.64% | |||
| Average Basic Shares Outstanding | 0.32% | 0.59% | |||
| Average Diluted Shares Outstanding | 0.44% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||